Glossary entry (derived from question below)
English term or phrase:
APD334 exposure
Portuguese translation:
exposição ao/contacto com o APD334
Added to glossary by
expressisverbis
Mar 7, 2016 20:53
8 yrs ago
English term
Brazil
Genuine dedication and professionalism
Native in: Portuguese (Variant: Brazilian) 
Works in: English to Portuguese, Spanish to Portuguese
APD334 exposure
English to Portuguese
Other
Medical (general)
APD334 exposure after oral administration was measured after 1.0 mg/kg in rodents and 3.0 mg/kg in dogs and monkeys.
Proposed translations
(Portuguese)
| 4 +4 | exposição ao/contacto com o APD334 |
expressisverbis
|
Change log
Apr 19, 2016 10:58: expressisverbis Created KOG entry
Proposed translations
+4
15 mins
expressisverbis
Portugal
Portugal
Native in Portuguese
Specializes in field
Portugal
Translator and Terminologist
Native in: Portuguese
Works in: English to Portuguese, French to Portuguese, Spanish to Portuguese
Related KudoZ points
:
263
Selected
exposição ao/contacto com o APD334
Diria assim.
O APD334 é um potencial fármaco para o tratamento de doenças autoimunes, descoberto e sob investigação/estudo pela empresa Arena.
Arena está investigando otros compuestos muy interesantes, como APD334, que parece haber demostrado cualidades y potencial para el tratamiento de múltiples enfermedades autoinmunes, incluyendo esclerosis múltiple, psoriasis y artritis reumatoide. Han logrado optimizar el producto de tal manera que parece reducirse la gravedad de la enfermedad en estado preclínico.
http://nasdaqlandia.com/arna-arena-pharmaceuticals-inc-recue...
SAN DIEGO , 05 de abril 2013 / PRNewswire / – Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) anunció hoy el inicio de la administración en la Fase 1 de ensayo clínico de APD334, un candidato nuevo fármaco oral que actúa sobre la esfingosina 1-fosfato receptor subtipo 1 (S1P 1) para el tratamiento potencial de enfermedades autoinmunes.
https://blogsclerosismultiple.wordpress.com/2013/04/05/arena...
Drug Candidate for Treatment of Autoimmune Diseases
APD334, an orally available S1P1 receptor modulator, discovered by Arena, has therapeutic potential in autoimmune diseases such as ulcerative colitis. S1P1 receptors have been demonstrated to be involved in the modulation of several biological responses, including lymphocyte trafficking from lymph nodes to the peripheral blood. By isolating subpopulations of lymphocytes in lymph nodes, fewer immune cells are available in the circulating blood to effect tissue damage.
http://www.arenapharm.com/apd334
--------------------------------------------------
Note added at 19 mins (2016-03-07 21:12:24 GMT)
--------------------------------------------------
As primeira referências estão em espanhol, mas penso que são compreensíveis.
O APD334 é um potencial fármaco para o tratamento de doenças autoimunes, descoberto e sob investigação/estudo pela empresa Arena.
Arena está investigando otros compuestos muy interesantes, como APD334, que parece haber demostrado cualidades y potencial para el tratamiento de múltiples enfermedades autoinmunes, incluyendo esclerosis múltiple, psoriasis y artritis reumatoide. Han logrado optimizar el producto de tal manera que parece reducirse la gravedad de la enfermedad en estado preclínico.
http://nasdaqlandia.com/arna-arena-pharmaceuticals-inc-recue...
SAN DIEGO , 05 de abril 2013 / PRNewswire / – Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) anunció hoy el inicio de la administración en la Fase 1 de ensayo clínico de APD334, un candidato nuevo fármaco oral que actúa sobre la esfingosina 1-fosfato receptor subtipo 1 (S1P 1) para el tratamiento potencial de enfermedades autoinmunes.
https://blogsclerosismultiple.wordpress.com/2013/04/05/arena...
Drug Candidate for Treatment of Autoimmune Diseases
APD334, an orally available S1P1 receptor modulator, discovered by Arena, has therapeutic potential in autoimmune diseases such as ulcerative colitis. S1P1 receptors have been demonstrated to be involved in the modulation of several biological responses, including lymphocyte trafficking from lymph nodes to the peripheral blood. By isolating subpopulations of lymphocytes in lymph nodes, fewer immune cells are available in the circulating blood to effect tissue damage.
http://www.arenapharm.com/apd334
--------------------------------------------------
Note added at 19 mins (2016-03-07 21:12:24 GMT)
--------------------------------------------------
As primeira referências estão em espanhol, mas penso que são compreensíveis.
4 KudoZ points awarded for this answer.
Something went wrong...